Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
A new ISAPS report shows a facial procedure has overtaken liposuction as the most-performed surgery worldwide.
An open-access paper describes PIILIF, a hidden follicle-centered inflammatory pattern that may interfere with standard pattern hair loss treatments, even in normal-appearing scalp.